Cantel Medical Investor Presentation June 2016

Cantel Medical is a NYSE-listed leader in Infection Prevention & Control (IP&C) solutions. The presentation outlines the company's business strategy, financial performance, and growth initiatives. As of January 31, 2016, the company reported $605 million in sales for the trailing twelve months.